T3D Therapeutics, Inc.
PrivateLast Round
Grant
Oct 4, 2022
Total Funding Raised
$27.2M
Company Overview
T3D Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in North Carolina. Its latest recorded funding round was a Grant round in October 2022.
T3D Therapeutics, Inc. is a clinical-stage drug development company that develops a drug therapy designed to stop and reverse the course of Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
T3D Therapeutics, Inc. Comparables
Compare T3D Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cerecin | 81% | |
| BioVie Inc. | 79% | |
| Aquinnah Pharmaceuticals | 78% |
For institutional investors. Book with your work email.
T3D Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 4, 2022 | ||||
| VC Round | Aug 26, 2022 | ||||
| Grant | Aug 27, 2020 | ||||
| Series B | Nov 4, 2019 | ||||
| Grant | May 20, 2019 | ||||
VC Round | Jan 12, 2018 |
For institutional investors. Book with your work email.
T3D Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 176% MoM.
- May 12, 2026
Monthly visitors grew 70% MoM.
For institutional investors. Book with your work email.
T3D Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about T3D Therapeutics, Inc.'s valuation, stock price, and market status.
Is T3D Therapeutics, Inc. a public or private company?
T3D Therapeutics, Inc. is a private company.
What is the current stock price of T3D Therapeutics, Inc.?
T3D Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks T3D Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is T3D Therapeutics, Inc. worth (valuation)?
Valuation information for T3D Therapeutics, Inc. is not publicly available.
Can I buy T3D Therapeutics, Inc. stock?
T3D Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was T3D Therapeutics, Inc.'s last funding round?
T3D Therapeutics, Inc.'s most recent funding round was Grant on October 4, 2022.
Who are the main investors in T3D Therapeutics, Inc.?
Key investors in T3D Therapeutics, Inc. include National Institute on Aging.
Will T3D Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for T3D Therapeutics, Inc..
How can I track T3D Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in T3D Therapeutics, Inc.'s shares on secondary markets.